Non-O Blood Group Tied to Higher CAD, MI Risk

This article originally appeared here.
Share this content:
Non-O Blood Group Tied to Higher CAD, MI Risk
Non-O Blood Group Tied to Higher CAD, MI Risk

WEDNESDAY, Sept. 9, 2015 (HealthDay News) -- Having non-O blood group may be an independent risk factor for coronary artery disease (CAD) and myocardial infarction, according to a meta-analysis published in the Sept. 1 issue of The American Journal of Cardiology.

Hisato Takagi, M.D., Ph.D., and Takuya Umemoto, M.D., Ph.D., on behalf of the All-Literature Investigation of Cardiovascular Evidence Group, conducted a literature review (January 2001 to March 2015) to identify case-control, cross-sectional, or cohort studies reporting adjusted odds ratios (ORs) and hazard ratios (HRs) for CAD in subjects with non-O versus O blood group.

The researchers included 12 relative risk estimates in 10 eligible studies. Based on pooled analysis, the non-O blood group was associated with a statistically significant 14 percent increase in CAD incidence compared to O blood group (OR/HR, 1.14). No evidence of significant publication bias was seen. When eight studies reporting data regarding (acute) myocardial infarction (MI) were pooled, similar statistically significant results unfavorable to the non-O blood group were seen (OR/HR, 1.16).

"In conclusion, we found that based on a meta-analysis of 10 studies enrolling a total of 174,945 participants, non-O blood group appears to be an independent risk factor for CAD and MI," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths